株探米国株
日本語 英語
エドガーで原本を確認する
false 0001113232 0001113232 2025-02-10 2025-02-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 10, 2025

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-30941   34-1818596
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts   01915
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (978) 787-4000

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share ACLS NASDAQ Global Select Market

 

 

 


 

Item 2.02 Results of Operations and Financial Condition

 

On February 10, 2025, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter and year ended December 31, 2024. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
     
99.1   Press Release dated February 10, 2025. Filed herewith
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 10, 2025 Axcelis Technologies, Inc.
   
  By: /s/ James Coogan
    James Coogan
    Executive Vice President
    and Chief Financial Officer

 

 

3

EX-99.1 2 tm255435d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

Axcelis Announces Financial Results for Fourth Quarter and Full Year 2024

 

Q4 Highlights:

 

· Revenue of $252.4 million
· Operating Margin of 21.6%
· Diluted earnings per share of $1.54

 

BEVERLY, Mass.— Feb. 10, 2025—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024.

 

For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income for the year was $201 million with diluted earnings per share of $6.15, compared to net income of $246.3 million and diluted earnings per share of $7.43 in 2023. Gross margin for the year was 44.7%, compared to 43.5% in 2023.

 

The Company reported fourth quarter revenue of $252.4 million, compared to $256.6 million for the third quarter of 2024. Gross margin for the quarter was 46.0%, compared to 42.9% in the third quarter. Operating profit for the quarter was $54.5 million, compared to $46.9 million for the third quarter. Net income for the quarter was $50 million, or $1.54 per diluted share, compared to $48.6 million, or $1.49 per diluted share in the third quarter.

 

President and CEO Russell Low commented, “Axcelis exited the year on a strong note, with fourth quarter revenue and profitability exceeding our expectations. As we look ahead to 2025, we anticipate a near term cyclical digestion period, as customers absorb the robust investments they’ve made into mature node capacity over the past few years – particularly in China. We are focused on capturing the long-term growth opportunities that lie ahead by investing in product innovation, managing our costs, and working closely with customers on their technology roadmaps – all of which will put us in an even stronger position for the next upturn.”

 

Executive Vice President and Chief Financial Officer Jamie Coogan said, “We are pleased with our financial execution in 2024. Despite a decline in revenue, we were able to deliver higher gross margins, generate solid free cash flow, return capital to shareholders via buyback, and exit the year with a stronger balance sheet that allows us to invest during this cyclical digestion period and drive long term value creation.”

 

 


 

 

 

Business Outlook

 

For the first quarter ending March 31, 2025, Axcelis expects revenues of approximately $185 million, and earnings per diluted share of approximately $0.38.

 

Fourth Quarter and Full Year 2024 Conference Call

 

The Company will host a call to discuss the results for the fourth quarter and full year 2024 on Tuesday, February 11, 2025, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:

 

https://register.vevent.com/register/BIb4b94bbc1cf744869eeb20b9a9be88a7
Webcast replays will be available for 30 days following the call.

 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

 


 

 

 

CONTACTS:

 

Investor Relations Contact:

David Ryzhik

Senior Vice President, Investor Relations and Corporate Strategy

Telephone: (978) 787-2352

Email: David.Ryzhik@axcelis.com

 

Press/Media Relations Contact: 

Maureen Hart

Senior Director, Corporate & Marketing Communications

Telephone: (978) 787-4266

Email: Maureen.Hart@axcelis.com

 

 


 

 

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

    Three months ended     Twelve months ended  
    December 31,     December 31,  
    2024     2023     2024     2023  
Revenue:                        
Product   $ 241,254     $ 300,603     $ 976,881     $ 1,095,650  
Services     11,163       9,685       40,984       34,954  
Total revenue     252,417       310,288       1,017,865       1,130,604  
Cost of revenue:                                
Product     125,402       163,801       524,451       608,112  
Services     10,792       8,591       38,760       31,191  
Total cost of revenue     136,194       172,392       563,211       639,303  
Gross profit     116,223       137,896       454,654       491,301  
Operating expenses:                                
Research and development     27,654       24,911       105,497       96, 907  
Sales and marketing     16,563       16,659       68,046       62,805  
General and administrative     17,475       17,275       70,317       65,794  
Total operating expenses     61,692       58,845       243,860       225,506  
Income from operations     54,531       79,051       210,794       265,795  
Other income (expense):                                
Interest income     6,277       5,375       24,403       18,199  
Interest expense     (1,444 )     (1,320 )     (5,462 )     (5,347 )
Other, net     (719 )     4,300       539       (48 )
Total other income     4,114       8,355       19,480       12,804  
Income before income taxes     58,645       87,406       230,274       278,599  
Income tax provision     8,689       16,350       29,282       32,336  
Net income   $ 49,956     $ 71,056     $ 200,992     $ 246,263  
Net income per share:                                
Basic   $ 1.54     $ 2.17     $ 6.17     $ 7.52  
Diluted   $ 1.54     $ 2.15     $ 6.15     $ 7.43  
Shares used in computing net income per share:                                
Basic weighted average shares of common stock     32,424       32,708       32,552       32,758  
Diluted weighted average shares of common stock     32,514       33,031       32,704       33,165  

 

 


 

 

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

             
    December 31,     December 31,  
    2024     2023  
ASSETS
Current assets:                
Cash and cash equivalents   $ 123,512     $ 167,297  
Short-term investments     447,831       338,851  
Accounts receivable, net     203,149       217,964  
Inventories, net     282,225       306,482  
Prepaid income taxes     6,420        
Prepaid expenses and other current assets     60,471       49,397  
Total current assets     1,123,608       1,079,991  
Property, plant and equipment, net     53,784       53,971  
Operating lease assets     29,621       30,716  
Finance lease assets, net     15,346       16,632  
Long-term restricted cash     7,552       6,654  
Deferred income taxes     68,277       53,428  
Other assets     50,593       40,575  
Total assets   $ 1,348,781     $ 1,281,967  
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:                
Accounts payable   $ 46,928     $ 54,400  
Accrued compensation     25,536       31,445  
Warranty     13,022       14,098  
Income taxes           6,164  
Deferred revenue     94,673       164,677  
Current portion of finance lease obligation     1,345       1,511  
Other current liabilities     26,018       12,834  
Total current liabilities     207,522       285,129  
Long-term finance lease obligation     42,329       43,674  
Long-term deferred revenue     43,501       46,208  
Other long-term liabilities     42,639       42,074  
Total liabilities     335,991       417,085  
                 
Stockholders’ equity:                
Common stock, $0.001 par value, 75,000 shares authorized; 32,365 shares issued and outstanding at December 31, 2024; 32,685 shares issued and outstanding at December 31, 2023     32       33  
Additional paid-in capital     548,654       547,189  
Retained earnings     470,318       319,506  
Accumulated other comprehensive loss     (6,214 )     (1,846 )
Total stockholders’ equity     1,012,790       864,882  
Total liabilities and stockholders’ equity   $ 1,348,781     $ 1,281,967  

 

 


 

 

 

Axcelis Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

    Three months ended     Twelve months ended  
    December 31,     December 31,  
    2024     2023     2024     2023  
Cash flows from operating activities                                
Net income   $ 49,956     $ 71,056     $ 200,992     $ 246,263  
Adjustments to reconcile net income to net cash provided by operating activities:                                
Depreciation and amortization     4,267       3,581       15,809       13,069  
Stock-based compensation expense     5,380       5,239       20,951       18,269  
Other     (442 )     (14,565 )     (11,532 )     (23,503 )
Change in operating assets and liabilities, net     (46,381 )     264       (85,402 )     (97,229 )
Net cash provided by operating activities     12,780       65,575       140,818       156,869  
                                 
Cash flows from investing activities                                
Expenditures for property, plant and equipment and capitalized software     (4,658 )     (10,153 )     (12,181 )     (20,656 )
Other changes in investing activities, net     13,779       (16,526 )     (96,545 )     (80,202 )
Net cash provided by (used in) investing activities     9,121       (26,679 )     (108,726 )     (100,858 )
                                 
Cash flows from financing activities                                
Repurchase of common stock     (15,131 )     (15,001 )     (60,489 )     (52,499 )
Other changes from financing activities, net     588       (22 )     (10,703 )     (15,769 )
Net cash used in financing activities     (14,543 )     (15,023 )     (71,192 )     (68,268 )
                                 
Effect of exchange rate changes on cash and cash equivalents     (3,013 )     1,128       (3,787 )     (139 )
Net increase (decrease) in cash, cash equivalents and restricted cash     4,345       25,001       (42,887 )     (12,396 )
                                 
Cash, cash equivalents and restricted cash at end of period   $ 131,064     $ 173,951     $ 131,064     $ 173,951